All Stories
- ArticleCell-free chromatin particles released from dying cells inflict mitochondrial damage and ROS production in living cells
- ArticleImmune checkpoint inhibitors face competition – Indian research suggests
- ArticleCancer research: in need of introspection
- ArticleA paradoxical synergism between Resveratrol and copper (II) with respect to degradation of DNA and RNA
- ArticleCirculating nucleic acids: a new class of physiological mobile genetic elements
- ArticlePullulan-histone antibody nanoconjugates for the removal of chromatin fragments from systemic circulation
- ArticleNucleic acids in circulation: Are they harmful to the host?
- ArticleBreast cancer screening in developing countries
- ArticleWhy Is Modern Medicine Stuck in a Rut?
- ArticleScreening for breast cancer: is it globally applicable?
- ArticleThe disconnection between tumor response and survival
- ArticleKeeping abreast of the issues
- ArticleTIMING OF SURGERY WITH REGARD TO THE MENSTRUAL CYCLE IN WOMEN WITH PRIMARY BREAST CANCER
- ArticleMulticentricity and recurrence of breast cancer
- ArticlePrognosis of breast cancer: Evidence for interaction between c-erbB-2 overexpression and number of involved axillary lymph nodes
- ArticleAxillary lymph node metastasis in breast cancer: Prognostic indicator or lead-time bias?
- ArticleCorrelations between c-erbβ-2 Oncogene Amplification and the Expression of Its mRNA and Protein in Human Breast Carcinomas
- ArticleConsensus guidelines and clinical practice in breast cancer
- ArticleAn Inverse Relationship Between Intracellular Prolactin and Growth Hormone and Estrogen Receptor Status in Human Breast Cancers
- ArticleSomatomedins and proteolytic bioactivation of prolactin and growth hormone
- ArticleA novel “Cleaved Prolactin” in the rat pituitary: Part I biosynthesis, characterization and regulatory control
- ArticleA novel “Cleaved Prolactin” in the rat pituitary: Part II in vivo mammary mitogenic activity of its N-terminal 16K moiety